Eicosanoids and cancer

doi:10.1038/nrc2809

Paper

Eicosanoids and cancer

Published Mar 1, 2010 · Dingzhi Wang, R. Dubois

Nature Reviews Cancer

Q1 SJR score

1,686

Citations

93

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Literature Review

Highly Cited

Study Snapshot

Eicosanoids play a complex role in tumor development and progression, potentially providing new markers for diagnostic and prognostic purposes and identifying new therapeutic strategies in cancer treatment.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Paper

Eicosanoids and cancer

References

Citations

Molecular Abnormalities and Carcinogenesis in Barrett’s Esophagus: Implications for Cancer Treatment and Prevention

Understanding the molecular mechanisms underlying Barrett's esophagus carcinogenesis can improve prevention, surveillance, and treatment strategies, ultimately reducing the global burden of esophageal adenocarcinoma.

Investigating 1,2,3‐Bistriazole‐Functionalized Sn (II) Chemosensors for COX‐2 Detection

1,2,3-bis-triazole-functionalized Sn (II) chemosensors show high sensitivity and selectivity for COX-2 detection, with potential anti-inflammatory properties.

Immunoregulatory mechanisms of the arachidonic acid pathway in cancer.

The arachidonic acid pathway influences tumor progression by modulating immune responses, and understanding its role may lead to more effective anticancer immunotherapies.

CML With Mutant ASXL1 Showed Decreased Sensitivity to TKI Treatment via Upregulation of the ALOX5-BLTR Signaling Pathway.

CML patients with mutated ASXL1 show decreased sensitivity to TKI treatment due to overexpression of the ALOX5-BLTR signaling pathway, making the ALOX5-BLTR pathway a potential therapeutic target.

Nrf2/cyclooxygenase 2 signaling in Cr(VI)-induced carcinogenesis.

COX-2 plays an oncogenic role in chromium-induced lung cancer, with Nrf2 and microRNA-379 playing novel regulatory mechanisms.

The Adaptation of MCF-7 Breast Cancer Spheroids to the Chemotherapeutic Doxorubicin: The Dynamic Role of Phase I Drug Metabolizing Enzymes

Early-stage drug resistance in breast cancer cells is driven by dynamic changes in drug metabolism, with CYP3A-dependent metabolism playing a prominent role.